Xiaomou Wei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Bone health and osteoporosis research 2
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Shengming DaiXiangyang ZhouDong WeiZhen WuHaixin HuangGuisheng LiWei LiangBing Li
- Journals
- Disease Markers (2 papers)Molecular Therapy (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)BMC Genomics (1 paper)Human Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaomou Wei
14 papers receiving 865 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 461
- Molecular Biology 737
- Immunology 181
- Immunology and Allergy 21
- Biomaterials 35
Countries citing papers authored by Xiaomou Wei
This map shows the geographic impact of Xiaomou Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomou Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomou Wei more than expected).
Fields of papers citing papers by Xiaomou Wei
This network shows the impact of papers produced by Xiaomou Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomou Wei. The network helps show where Xiaomou Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaomou Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2020 | 13 | |
| 3 | LncRNA TGFB2-AS1 regulates lung adenocarcinoma progression via act as a sponge for miR-340-5p to target EDNRB expression. | 2020 | 5 |
| 4 | 2018 | 20 | |
| 5 | 2018 | 14 | |
| 6 | 2017 | 34 | |
| 7 | 2016 | 8 | |
| 8 | 2016 | 2 | |
| 9 | 2016 | 14 | |
| 10 | 2015 | 49 | |
| 11 | 2014 | 6 | |
| 12 | 2014 | 20 | |
| 13 | 2009 | 16 | |
| 14 | Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer Hit paper breakdown → | 2008 | 670 |
About Xiaomou Wei
Xiaomou Wei is a scholar working on Orthopedics and Sports Medicine, Cancer Research, Molecular Biology, Immunology and Oncology, having authored 14 papers that have together received 876 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Bone Tissue Engineering Materials (2 papers), Lung Cancer Research Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Circular RNAs in diseases (2 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Cancer Research (461 citations), Molecular Biology (737 citations), Immunology (181 citations), Immunology and Allergy (21 citations) and Biomaterials (35 citations). Xiaomou Wei has collaborated with scholars based in China and United States. Frequent co-authors include Shengming Dai, Xiangyang Zhou, Dong Wei, Zhen Wu, Haixin Huang, Guisheng Li, Wei Liang, Bing Li, Haobo Pan and Xue Qin. Their work appears in journals such as Disease Markers, Molecular Therapy, Journal of Biomedical Materials Research Part B Applied Biomaterials, BMC Genomics and Human Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.